股市资讯 | 特朗普:我们有很好的机会与中国达成协议,香港25年来最大上市制度改革落地:尚未盈利的生物科技公司有可能赴港上市

wechat omage

美国股市

北京时间25日凌晨,美股周二收跌,3M与卡特彼勒股价重挫,拖累道指连续第五个交易日下滑。美债收益率攀升以及卡特彼勒暗示今年美国经济增长将会放缓,增大了大盘面临的压力。

美东时间4月24日16:00(北京时间4月25日04:00),道指跌424.56点,或1.74%,报24,024.13点;标普500指数跌35.73点,或1.34%,报2,634.56点;纳指跌121.25点,或1.70%,报7,007.35点。

美国财长访华,特朗普:美国有很大的机会与中国达成协议

中美贸易问题继续受到关注。美国总统唐纳德-特朗普说,财政部长史蒂文.努钦将在数日内前往中国就两国贸易争端进行谈判。“我们有很好的机会达成协议,” 特朗普在与法国总统马克龙举行会谈时说。不过他也表示,如果双方不能达成一致,美国对中国数百亿美元商品加征关税的提议将按计划生效。

此次中国之行将是努钦第一次以美国财长身份访华。他虽曾在华盛顿及在欧洲二十国集团会议期间会晤过中国同行,但努钦还从来没有在他们的主场与之见面。他的最近三位前任都在出任美国财长后的头几个月内访问了中国。

美股财报季表现强劲

财报仍然是周二市场的一个重要关注焦点。一大批重头企业在盘前公布了财报。迄今为止,美股财报季表现强劲,在已经公布了财报的标普500成份公司当中,有80%的企业盈利超出预期。而据FactSet数据,在2017年第四季度,业绩超出市场预期的标普500成分公司比例为73%。

美国10年期国债收益率站上3%关口 为2014年1月来首次

“投资者目前认为全球通胀环境正在恶化,贸易摩擦和制裁导致石油、金属、以及受到关税冲击的其它一些产品在某一阶段价格上涨,”瑞士联合私立银行的策略师Koon Chow说。“这就是美国债券出现当前走势的原因所在。” 23日,10年期美国国债收益率——抵押贷款和企业贷款的基准——升至2.995%的高点,在纽约触及2.98%。2年期美国国债收益率上升近2个基点,至2.48%。

 

香港股市

4月24日消息,中美风险因素有所缓解,H股全流通以及“新三板+H股”等多重利好刺激;此外,港交所今日收市后将公布引入同股不同权机制及生物科技企业上市的上市改革咨询总结,预计下周一 (30日) 起生效,即时接受上市申请。4月24日早盘,三大指数全部涨逾1%。午后恒指维持震荡。截至收盘,港股恒生指数涨1.26%,报30636.24点;国企指数涨2.04%,报12244.88点;红筹指数涨1.98%,报4492.61点;大市成交974.7亿港元。

内房股大幅回暖,今早板块个股普遍高开,盘中股价持续拉升,截至发稿,融创中国(01918)涨6.46%,碧桂园(02007)涨4.97%,中国恒大(03333)涨6.49%,绿城中国(03900)涨5%,万科企业(02202)涨3.43%。

保险股止跌回升,截至发稿,中国平安(02318)涨1.22%,报83.05港元,中国太平(00966)涨1.99%,中国人寿(601628)(02628)涨0.69%,中国太保(601601)(02601)涨2.07%。

本周四起港股通将暂停,下周三恢复。

本周四及周五港股通将暂停,至下周三才恢复,恐怕这几日港股成交不会有太大突破,恒指或将继续在上落范围内反复。

香港25年来最大上市制度改革。

香港交易所24日宣布,新订的《上市规则》条文将于4月30日生效,同日将按新制度接受新经济公司上市申请,预计首批公司将在6月或7月根据新制度上市。这是继H股后,香港资本市场25年来最大改革,将激发香港资本市场新活力。

经过几个月的公开咨询,港交所公布修改后的上市制度有几大亮点,即4月30日开始:

允许未能通过主板财务资格测试的生物科技公司上市;
允许“同股不同权”的公司上市;
允许为寻求在香港作第二上市的中资及国际公司设立新的第二上市渠道

中国股市

截至4月24日收盘,沪指报3128.93点,涨60.92点,涨幅1.99%,成交1955亿元;深成指报10556.82点,涨226.19点,涨幅2.19%,成交2568亿元;创业板报1806.86点,涨53.81点,涨幅3.07%,成交915.8亿元。

盘面上,次新股、国产软件、计算机应用、芯片概念、5G通信、网络安全等概念板块涨幅居前;海工装备、有色、黄金、园区开发、种植业与林业、煤炭开采等概念板块涨幅较小。

个股方面,光明地产、粤传媒、创意信息、天津普林、久立特材、二三四五、吉林高速等涨幅居前;万丰奥威、千山药机、亚星锚链、洽洽食品、中船科技、荣之联、中国铝业等跌幅居前。

关键词:股票,香港股市,港股,恒指,香港IPO,交易港股,美股,中国A股,股市资讯, 美国上市, 阿里巴巴股票,行业板块,银行股,特斯拉,暗盘,上市,高盛,美国IPO, 蚂蚁金服,蚂蚁金融,高盛,黑石,中方博鳌论坛,华尔街,特朗普的推特,股市警报,万科集团,碧桂园,融创中国,芯片,苹果股票,美国国债,高盛股票,上市制度改革,尚未盈利的生物科技公司

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com